Announcements

Archive by year: 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 |

Date	Title	Format
10/12/2002	Directors Appointed at ReGen Therapeutics Plc
10/12/2002	Results of EGM & Analysts' Presentation
14/11/2002	Notice of EGM
14/11/2002	Resignation of board member
13/11/2002	Publication of independent long-term study on Colostrinin™ shows positive results
24/10/2002	ReGen presents potential mode of action data for Colostrinin™ at International Conference on Alzheimer's Disease
17/10/2002	Patent Granted
26/09/2002	Interim Results for the 6 months to 30 June 2002
24/09/2002	Regen secures potential funding facility
17/09/2002	Update on potential funding
02/09/2002	Board Restructuring
11/07/2002	Substantial Shareholding
08/07/2002	ReGen Announces Positive Outcome of its 30 week Trial of Colostrinin™
19/06/2002	Substantial Shareholding
10/06/2002	ReGen Therapeutics successfully completes Interim funding round
08/05/2002	Preliminary Results for the Year Ended 31 December 2001
22/03/2002	Colostrinin™ continues trends towards efficacy in latest Interim findings from Clinical trial
04/03/2002	Share Issue
29/01/2002	Result of EGM
16/01/2002	Board Changes

If you are unable to view the PDF documents you may need to download the free Adobe Reader